pharma · Nasopharyngeal Carcinoma · Hepatocellular Carcinoma
Chinese Academy of
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chinese Academy of patent portfolio — 4 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- China, TAIZHOU, CN
- Employees
- 170
- Programs
- 24
- Drugs
- 538
- Patents
- 4
Chinese Academy of patents
4 pharmaceutical patents indexed for Chinese Academy of. 0 expire within 24 months.
Chinese Academy of has 4 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12383535
Hydrogen peroxide-responsive KEAP1-NRF2 ppi inhibitor prodrug, and preparation method therefor
granted -
US 12364671
Methods of administering vitamin A and lactic acid to gilts
granted -
US 12214021
Study on lactoferrin regulation of bone formation by means of vitamin D receptor
granted -
US 8486898
Compounds and method for inhibiting the activity of gelatinase and collagenase
granted
Frequently asked questions
How many patents does Chinese Academy of have?
4 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Chinese Academy of patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.